New Jersey Appeals Court Affirms Exclusion Of 2 Experts In 3,231 Accutane Cases

(January 21, 2020, 2:00 PM EST) -- JERSEY CITY, N.J. — A New Jersey state appeals court on Jan. 17 affirmed the exclusion of two plaintiff experts opinions for “methodological defects,” a ruling that the trial court applied to 3,231 other cases alleging that the acne drug Accutane caused plaintiffs to develop inflammatory bowel disease (In Re:  Accutane Litigation, No. A-4952-16T1, N.J. Super., App. Div., 2020 N.J. Super. Unpub. LEXIS 123)....

Attached Documents

Related Sections